Boteon Y, Wallace L, Boteon A, Mirza D, Mergental H, Bhogal R, et al. An effective protocol for pharmacological defatting of primary human hepatocytes which is non-toxic to cholangiocytes or intrahepatic endothelial cells. PLoS ONE. 2018;13:e0201419 pubmed publisher

Okumura T, Ohuchida K, Sada M, Abe T, Endo S, Koikawa K, et al. Extra-pancreatic invasion induces lipolytic and fibrotic changes in the adipose microenvironment, with released fatty acids enhancing the invasiveness of pancreatic cancer cells. Oncotarget. 2017;8:18280-18295 pubmed publisher

Ai L, Xu Q, Wu C, Wang X, Chen Z, Su D, et al. A20 Attenuates FFAs-induced Lipid Accumulation in Nonalcoholic Steatohepatitis. Int J Biol Sci. 2015;11:1436-46 pubmed publisher

Maruo S, Kuriyama I, Kuramochi K, Tsubaki K, Yoshida H, Mizushina Y. Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response. Bioorg Med Chem. 2011;19:5803-12 pubmed publisher

Mazimba O, Majinda R, Modibedi C, Masesane I, Cencic A, Chingwaru W. Tylosema esculentum extractives and their bioactivity. Bioorg Med Chem. 2011;19:5225-30 pubmed publisher

Brychtova K, Opatrilova R, Raich I, Kalinowski D, Dvorakova L, Placek L, et al. Investigating the activity of 2-substituted alkyl-6-(2,5-dioxopyrrolidin-1-yl)hexanoates as skin penetration enhancers. Bioorg Med Chem. 2010;18:8556-65 pubmed publisher

Cai H, Yan G, Zhang X, Gorbenko O, Wang H, Zhu W. Discovery of highly selective inhibitors of human fatty acid binding protein 4 (FABP4) by virtual screening. Bioorg Med Chem Lett. 2010;20:3675-9 pubmed publisher

Wecksler A, Garcia N, Holman T. Substrate specificity effects of lipoxygenase products and inhibitors on soybean lipoxygenase-1. Bioorg Med Chem. 2009;17:6534-9 pubmed publisher

Seierstad M, Breitenbucher J. Discovery and development of fatty acid amide hydrolase (FAAH) inhibitors. J Med Chem. 2008;51:7327-43 pubmed publisher

Chuang S, Velkov T, Horne J, Porter C, Scanlon M. Characterization of the drug binding specificity of rat liver fatty acid binding protein. J Med Chem. 2008;51:3755-64 pubmed publisher

Huang H, Chen Y, Ye J. Inhibition of hepatitis C virus replication by peroxidation of arachidonate and restoration by vitamin E. Proc Natl Acad Sci U S A. 2007;104:18666-70 pubmed

Chatterjee A, Chowdhury R. Bile and unsaturated fatty acids inhibit the binding of cholera toxin and Escherichia coli heat-labile enterotoxin to GM1 receptor. Antimicrob Agents Chemother. 2008;52:220-4 pubmed

Bruno M, Koeppe R, Andersen O. Docosahexaenoic acid alters bilayer elastic properties. Proc Natl Acad Sci U S A. 2007;104:9638-43 pubmed

Sulsky R, Magnin D, Huang Y, Simpkins L, Taunk P, Patel M, et al. Potent and selective biphenyl azole inhibitors of adipocyte fatty acid binding protein (aFABP). Bioorg Med Chem Lett. 2007;17:3511-5 pubmed

Diamandis P, Wildenhain J, Clarke I, Sacher A, Graham J, Bellows D, et al. Chemical genetics reveals a complex functional ground state of neural stem cells. Nat Chem Biol. 2007;3:268-73 pubmed

Balunas M, Su B, Landini S, Brueggemeier R, Kinghorn A. Interference by naturally occurring fatty acids in a noncellular enzyme-based aromatase bioassay. J Nat Prod. 2006;69:700-3 pubmed

Fang X, Shao L, Zhang H, Wang S. CHMIS-C: a comprehensive herbal medicine information system for cancer. J Med Chem. 2005;48:1481-8 pubmed